Larotaxel T15713
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Larotaxel is a taxane analogue with preclinical activity against taxane-resistant breast cancer. It can cross the blood-brain barrier and has a much lower affinity for P-glycoprotein 1. Larotaxel promotes tubulin assembly and stabilizing microtubules, ult
CAS nr:
156294-36-9
Purity:
98%
Molecular Weight:
831,9
SMILES:
O=C([C@]1([H])OC(C)=O)[C@@]23[C@@]([C@@H]([C@@]4(O)C(C)(C)C1=C([C@H](OC([C@H](O)[C@H](C5=CC=CC=C5)NC(OC(C)(C)C)=O)=O)C4)C)OC(C6=CC=CC=C6)=O)([H])[C@]7([C@@](OC7)([H])C[C@@H]2C3)OC(C)=O
Formula:
C45H53NO14
Pathway:
Others
Target:
Others
